Cargando…
PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments
Noninvasive determination of integrin expression has become an interesting approach in nuclear medicine. Since the discovery of the first (18)F-labeled cyclic RGD peptide as radiotracer for imaging integrin α (v) β (3) expression in vivo, there have been carried out enormous efforts to develop RGD p...
Autores principales: | Haubner, Roland, Maschauer, Simone, Prante, Olaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072020/ https://www.ncbi.nlm.nih.gov/pubmed/25013808 http://dx.doi.org/10.1155/2014/871609 |
Ejemplares similares
-
Recent Trends in Pharmaceutical Radiochemistry for Molecular PET Imaging
por: Prante, Olaf, et al.
Publicado: (2014) -
H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α
(5)
β
(1)?
por: Haubner, Roland, et al.
Publicado: (2014) -
Sweetening Pharmaceutical Radiochemistry by (18)F-Fluoroglycosylation: Recent Progress and Future Prospects
por: Shinde, Sandip S., et al.
Publicado: (2021) -
Radiopharmaceutical tracers for cardiac imaging
por: Manabe, Osamu, et al.
Publicado: (2017) -
In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor
por: Nebel, Natascha, et al.
Publicado: (2016)